NANAIMO, British Columbia--(BUSINESS WIRE)--Oct. 4, 2018--
Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research,
cultivation, production and distribution, today announced the pricing of
US$450 million aggregate principal amount of Convertible Senior Notes
due 2023 (the “notes”) in a private placement to qualified institutional
buyers pursuant to Rule 144A under the Securities Act of 1933, as
amended (the “Securities Act”). Any notes sold in Canada will only be
sold to accredited investors pursuant to an exemption from the
prospectus requirements of Canadian securities laws. Tilray also granted
the initial purchasers of the notes an option to purchase up to an
additional US$67.5 million aggregate principal amount of notes. The
offering was upsized from the previously announced US$400 million
aggregate principal amount.
The sale of the notes to the initial purchasers is expected to settle on
October 10, 2018, subject to the satisfaction of customary closing
conditions, and is expected to result in approximately US$435.0 million
in net proceeds to Tilray (or approximately US$500.5 million if the
initial purchasers exercise their option to purchase additional notes in
full) after deducting the initial purchasers’ discount and estimated
offering expenses payable by Tilray.
Tilray intends to use the net proceeds from this offering for working
capital, future acquisitions and general corporate purposes, and to
repay the approximately US$9.1 million existing mortgage related to its
facility in Nanaimo, British Columbia.
The notes will be senior unsecured obligations of Tilray and will bear
an interest at a rate of 5.00% per year, payable semiannually in arrears
on April 1 and October 1 of each year, beginning on April 1, 2019. The
notes will mature on October 1, 2023, unless earlier repurchased,
redeemed or converted.
The initial conversion rate for the notes is 5.9735 shares of Class 2
common stock per US$1,000 principal amount of notes (which is equivalent
to an initial conversion price of approximately US$167.41 per share).
Conversions of the notes will be settled in cash, shares of Tilray’s
Class 2 common stock or a combination thereof, at Tilray’s election. The
initial conversion price represents a conversion premium of
approximately 15% over the last reported sale price of US$145.57 per
share of Tilray’s Class 2 common stock on the Nasdaq Global Select
Market on October 4, 2018.
Prior to the close of business on the day immediately preceding April 1,
2023, the notes will be convertible at the option of the holders only
upon the satisfaction of specified conditions and during certain
periods. On and after April 1, 2023 until the close of business on the
second scheduled trading day immediately preceding the maturity date,
holders may convert their notes at their option regardless of these
conditions.
Holders may require Tilray to repurchase their notes upon the occurrence
of a fundamental change (as defined in the indenture governing the
notes) at a cash purchase price equal to the principal amount thereof
plus accrued and unpaid interest, if any.
Tilray may not redeem the notes prior to October 1, 2021. On or after
October 1, 2021 and on or before the 30th scheduled trading day
immediately before the maturity date, Tilray may redeem for cash all or
part of the notes if the last reported sale price of Tilray’s Class 2
common stock has been at least 130% of the conversion price then in
effect for at least 20 trading days (whether or not consecutive),
including the trading day immediately preceding the date on which Tilray
provides a notice of redemption, during any 30 consecutive trading day
period ending on, and including, the trading day immediately preceding
the date on which Tilray provides notice of redemption. The redemption
price for the notes will equal the principal amount of the notes to be
redeemed, plus accrued and unpaid interest, if any.
Neither the notes, nor any shares of Tilray's Class 2 common stock
issuable upon conversion of the notes, have been registered under the
Securities Act or any state securities laws, or qualified for
distribution by prospectus in Canada, and unless so registered, may not
be offered or sold in the United States absent registration or an
applicable exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act and other applicable
securities laws, or sold in Canada absent an exemption from the
prospectus requirements of Canadian securities laws.
This press release is neither an offer to sell nor a solicitation of an
offer to buy any securities, nor shall it constitute an offer,
solicitation or sale of any securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such
state or jurisdiction.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements”, which may
be identified by the use of words such as, “may”, “would”, “could”,
“will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”,
“forecast”, “project”, “estimate”, “outlook” and other similar
expressions, including statements related to whether Tilray will be able
to consummate the offering, the satisfaction of customary closing
conditions with respect to the offering of the notes, prevailing market
conditions, the anticipated use of net proceeds of the offering of the
notes which could change as a result of market conditions or for other
reasons, and the impact of general economic, industry or political
conditions in the United States or internationally. Forward-looking
statements are not a guarantee of future performance and are based upon
a number of estimates and assumptions of management in light of
management’s experience and perception of trends, current conditions and
expected developments, as well as other factors that management believes
to be relevant and reasonable in the circumstances, including
assumptions in respect of current and future market conditions. Actual
results, performance or achievement could differ materially from that
expressed in, or implied by, any forward-looking statements in this
press release, and, accordingly, you should not place undue reliance on
any such forward-looking statements and they are not guarantees of
future results. Forward-looking statements involve significant risks,
assumptions, uncertainties and other factors that may cause actual
future results or anticipated events to differ materially from those
expressed or implied in any forward-looking statements. Please see the
heading “Risk Factors” in Tilray’s Quarterly Report on Form 10-Q for the
quarter ended June 30, 2018 and the risks discussed in Tilray’s other
filings with the Securities and Exchange Commission for a discussion of
the material risk factors that could cause actual results to differ
materially from the forward-looking information. Tilray does not
undertake to update any forward-looking statements that are included
herein, except in accordance with applicable securities laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181004005887/en/
Source: Tilray Inc.
Tilray Inc.
Media:
Zack Hutson, +1-415-534-5541
zack.hutson@tilray.com
or
Investors:
Katie
Turner, +1-646-277-1228
Katie.turner@icrinc.com
